Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase I/II Study to Evaluate the Safety and Efficacy of TWB-103 in Treating Lower Limb Ulcers on Patients With Diabetes Mellitus

NCT03624023 is registered in ClinicalTrials.gov with Transwell Biotech Co., Ltd. as lead sponsor.

NCT NCT03624023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03624023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase I/II Study to Evaluate the Safety and Efficacy of TWB-103 in Treating Lower Limb Ulcers on Patients With Diabetes Mellitus
Lead sponsor
Transwell Biotech Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
December 19, 2019
Completion date
July 9, 2021
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer